SKVI — Skinvisible Cashflow Statement
0.000.00%
- $1.22m
- $6.95m
- $0.02m
- 52
- 30
- 47
- 38
Annual cashflow statement for Skinvisible, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1.45 | -1.07 | -1.22 | -2.38 | -0.566 |
Amortisation | |||||
Non-Cash Items | 0.664 | 0.693 | 0.484 | 1.31 | -0.574 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.797 | 0.736 | 0.767 | 0.981 | 1.05 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | 0.046 | 0.375 | 0.045 | -0.077 | -0.07 |
Capital Expenditures | -0.017 | -0.021 | -0.003 | -0.009 | -0.009 |
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | — | — | — | — |
Sale of Fixed Assets | |||||
Cash from Investing Activities | -0.017 | -0.021 | -0.003 | -0.009 | -0.009 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.006 | -0.324 | -0.027 | 0.006 | 0.088 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.035 | 0.03 | 0.015 | -0.08 | 0.009 |